scispace - formally typeset
A

Anirban Ghosh

Researcher at Bose Institute

Publications -  59
Citations -  1931

Anirban Ghosh is an academic researcher from Bose Institute. The author has contributed to research in topics: Gene & Peptide. The author has an hindex of 24, co-authored 50 publications receiving 1617 citations. Previous affiliations of Anirban Ghosh include Jawaharlal Nehru University & Seattle Biomed.

Papers
More filters
Journal ArticleDOI

Regulation of Human p53 Activity and Cell Localization by Alternative Splicing

TL;DR: The expression of p47 through alternative splicing of the p53 gene resulting in the expression of a novel p53 mRNA encodes an N-terminally deleted isoform of p53 termed p47, which has a major influence over p53 activity at least in part through controlling p53 ubiquitination and cell localization.
Journal ArticleDOI

Immunization with A2 protein results in a mixed Th1/Th2 and a humoral response which protects mice against Leishmania donovani infections

TL;DR: It is shown that immunization of mice with recombinant A2 protein conferred significant protection against challenge infection with Leishmania donovani, and A2 represents a potential antigen for protection against infection with L.Donovani and VL.
Journal ArticleDOI

Comparison of the A2 Gene Locus in Leishmania donovani and Leishmania major and Its Control over Cutaneous Infection

TL;DR: It is demonstrated that although L. major contains A2 gene regulatory sequences, the multiple repeats that exist in L. donovani A2 protein coding regions are absent, and the remaining corresponding A2 sequences appear to represent non-expressed pseudogenes, and it was possible to restore amastigote-specific A2 expression to L.major, confirming that A2 regulatory sequences remain functional inL.
Journal ArticleDOI

Indolicidin targets duplex DNA: structural and mechanistic insight through a combination of spectroscopy and microscopy.

TL;DR: High‐resolution structural information is provided on the interaction between indolicidin and DNA, which will be beneficial for the design of novel therapeutic antibiotics based on peptide scaffolds.
Journal ArticleDOI

Antimicrobial Peptides: Insights into Membrane Permeabilization, Lipopolysaccharide Fragmentation and Application in Plant Disease Control.

TL;DR: VG16KRKP, a non-toxic and non-hemolytic analogue of VG16, shows significant antimicrobial activity against Gram-negative E. coli and plant pathogens X. oryzae and X. campestris, as well as against human fungal pathogens C. albicans and C. grubii.